Search Within

Jin Xu

Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Breast Medicine Service (6)
  3. Department of Medicine (6)
  4. Department of Pathology and Laboratory Medicine (6)
  5. Population Sciences Research Program (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Chau Dang (6)
  2. Dara Ross (6)
  3. Edi Brogi (6)
  4. Hannah Wen (6)
  5. Katia Ventura (6)
  6. Larry Norton (6)

More People

Years
  1. 2020 (1)
  2. 2019 (7)
Publications
  1. Laboratory Investigation (3)
  2. Modern Pathology (3)
  3. Archives of Pathology & Laboratory Medicine (1)
  4. Breast Cancer Research and Treatment (1)
Publishers
  1. Nature Publishing Group (3)
  2. Nature Research (3)
  3. College of American Pathologists (1)
  4. Springer (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0
    Journal Article

    Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    Archives of Pathology & Laboratory Medicine (2020)

    Fulltext@MSK | Save
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio < 2, HER2 copy number ≥ 4 and < 6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • MELF-like pattern in myoinvasive clear cell and serous endometrial carcinoma
    Meeting Abstract

    Cagaanan, A.; Xu, J.; Weisman, P.; McGregor, S.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio <2, HER2 copy number ≥ 4 and <6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • MELF-like pattern in myoinvasive clear cell and serous endometrial carcinoma
    Meeting Abstract

    Cagaanan, A.; Xu, J.; Weisman, P.; McGregor, S.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save